BioMed Research International / 2015 / Article / Fig 3

Research Article

Secretome Identifies Tenascin-X as a Potent Marker of Ovarian Cancer

Figure 3

Correlation between tenascin-X and CA-125 levels in serum of benign and cancerous ovarian patients.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.